Dolutegravirintermediate-1是Dolutegravir的一种新合成中间体来自专利WO2016125192A2。Dolutegravir是一种整合酶抑制剂,用于治疗人类免疫缺陷病毒(HIV)-1感染。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Dolutegravir intermediate-1 is a novel synthetic intermediate of dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-l infection.
[1]. Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
没有评价数据